$CLNN 4/A SEC Filings

Filed On	Filing
30 Sep 2025	Form 4/A: Mortenson Mark, Chief Science Officer Granted 40,000 stock option
30 Sep 2025	Form 4/A: Etherington Robert Dee, Director Granted 40,000 stock option
30 Sep 2025	Form 4/A: Brown Morgan R, Chief Financial Officer Holds 10,000 stock option (exercise price $5.88, expires Sep 24, 2035)
15 Feb 2022	Form 4/A: Stevens John Henry, Director Granted 5,721 Stock Options (Right to buy)
27 May 2021	Form 4/A: Costello Fiona, Director Granted 31,788 Stock Options (Right to buy)
25 May 2021	Form 4/A: Jacobovitz Shalom, Director Granted 32,418 Stock Options (Right to buy)
25 May 2021	Form 4/A: Matlin David J, Director Granted 33,170 Stock Options (Right to buy)
25 May 2021	Form 4/A: Gay Jonathon, Director Granted 31,788 Stock Options (Right to buy)
25 May 2021	Form 4/A: Stevens John Henry, Director Granted 31,869 Stock Options (Right to buy)
25 May 2021	Form 4/A: Mosca Alison, Director Granted 32,479 Stock Options (Right to buy)
25 May 2021	Form 4/A: Ugwumba Chidozie, Director Granted 31,930 Stock Options (Right to buy)

Comments